Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
45,655 results
  • StatPearls [BOOK]
  • BOOKStatPearls Publishing: Treasure Island (FL)
  • Singh Dharminder D Kaweah Delta Medical Center Saadabadi Abdolreza A Western University/ Kaweah Delta
  • Naltrexone is an opioid antagonist used to treat alcohol use disorder and opioid dependence. It was developed in 1963 and patented in 1967. In 1984, naltrexone was approved for medical use in the Uni...
  • Boosting treatment stabilization in patients of amphetamine-type stimulant use disorder. [Journal Article]
  • IJInt J Drug Policy 2018 Nov 30; 64:1-4
  • Chen IC, Chen CJ, … Lan TH
  • CONCLUSIONS: The mandatory treatment modality boosted treatment stabilization for patients of amphetamine-type stimulant use disorder. The major benefit of using the monitoring model is the ability to monitor boosting effects of stabilization. Results supported the effectiveness of this mandatory treatment modality and can be implemented in deferred-prosecution based treatment modality.
New Search Next